FEATURED
FDA approves Roche’s Xofluza for Influenza post-exposure prophylaxis
Roche has announced that the U.S. FDA has granted supplemental New Drug Application (sNDA) approval for Xofluza, the first single-dose
DEALS
EC to purchase up to 160 mill doses of Moderna’s COVID-19 vaccine
Moderna announced today that the European Commission has approved an agreement to buy 80 million doses of mRNA-1273, Moderna’s COVID-19
PRESS RELEASES
Watlow launches LEGACY SERIES Panel-mount Temperature Controllers
Watlow® has introduced its new LEGACY SERIES Panel-mount Temperature Controllers, which offer simple menus and are perfectly suited for basic
Comments & Analysis
The Acceleration of Digitalisation in Pharma in 2020
This year, more than ever has required the pharma industry to dive into digitalisation in all shapes and forms. With
RESOURCES
Download the latest pharmaceutical case studies, white papers, research papers and product brochures
Integrated three-way improvement program for early-stage peptide development
Improving half-life and cell penetration in a peptide identified to efficiently interact with a newly discovered intracellular pathway. A Copexis
LATEST PROJECTS
AI Innovation Lab, BioNTech and InstaDeep, London and Mainz
BioNTech and InstaDeep have entered into an agreement to establish a joint AI Innovation Lab in London, United Kingdom and
CLINICAL TRIALS
Trial data shows AstraZeneca’s COVID-19 vaccine was highly effective
AstraZeneca announced today, that interim trial data has shown it’s COVID-19 vaccine candidate AZD1222, developed in collaboration with the University
REGULATORY
UK approves Pfizer and BioNTech’s COVID-19 vaccine for emergency use
The UK has become the first western country to approve Pfizer and BioNTech’s COVID-19 vaccine for emergency use. The United
